Yost Capital Management LP Buys Shares of 30,000 Zoetis Inc. (NYSE:ZTS)

Yost Capital Management LP purchased a new position in shares of Zoetis Inc. (NYSE:ZTS) during the 2nd quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm purchased 30,000 shares of the company’s stock, valued at approximately $5,201,000. Zoetis comprises approximately 8.7% of Yost Capital Management LP’s investment portfolio, making the stock its 7th largest holding.

Other institutional investors have also modified their holdings of the company. Price T Rowe Associates Inc. MD lifted its position in Zoetis by 31.0% during the fourth quarter. Price T Rowe Associates Inc. MD now owns 13,716,681 shares of the company’s stock worth $2,707,262,000 after buying an additional 3,244,074 shares during the period. Sarasin & Partners LLP boosted its position in shares of Zoetis by 546.3% in the second quarter. Sarasin & Partners LLP now owns 2,253,590 shares of the company’s stock worth $390,682,000 after acquiring an additional 1,904,899 shares during the last quarter. Swedbank AB purchased a new stake in Zoetis in the first quarter valued at approximately $210,815,000. Public Employees Retirement Association of Colorado acquired a new position in Zoetis during the fourth quarter worth approximately $242,757,000. Finally, CIBC Private Wealth Group LLC raised its stake in Zoetis by 122.6% during the fourth quarter. CIBC Private Wealth Group LLC now owns 1,448,665 shares of the company’s stock worth $285,923,000 after purchasing an additional 797,884 shares during the period. Institutional investors and hedge funds own 92.80% of the company’s stock.

Zoetis Price Performance

Shares of NYSE ZTS opened at $193.24 on Friday. The company has a market capitalization of $88.17 billion, a price-to-earnings ratio of 37.23, a PEG ratio of 2.98 and a beta of 0.88. The company has a debt-to-equity ratio of 1.32, a current ratio of 3.45 and a quick ratio of 2.09. Zoetis Inc. has a 1-year low of $144.80 and a 1-year high of $201.92. The business has a 50-day moving average of $184.42 and a 200-day moving average of $174.44.

Zoetis (NYSE:ZTS) last issued its quarterly earnings data on Tuesday, August 6th. The company reported $1.56 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.49 by $0.07. Zoetis had a net margin of 26.29% and a return on equity of 50.67%. The company had revenue of $2.36 billion during the quarter, compared to the consensus estimate of $2.31 billion. During the same quarter last year, the company earned $1.41 earnings per share. Zoetis’s revenue for the quarter was up 8.3% on a year-over-year basis. On average, equities analysts anticipate that Zoetis Inc. will post 5.84 EPS for the current fiscal year.

Wall Street Analyst Weigh In

Several analysts have recently issued reports on ZTS shares. BTIG Research boosted their price objective on shares of Zoetis from $220.00 to $225.00 and gave the company a “buy” rating in a research note on Monday, August 12th. Argus raised Zoetis to a “strong-buy” rating in a research report on Friday, August 9th. Piper Sandler raised their price objective on Zoetis from $195.00 to $210.00 and gave the stock an “overweight” rating in a report on Wednesday, August 14th. Finally, Stifel Nicolaus lifted their price objective on Zoetis from $200.00 to $210.00 and gave the company a “buy” rating in a research note on Wednesday. Nine equities research analysts have rated the stock with a buy rating and one has given a strong buy rating to the stock. Based on data from MarketBeat, the company presently has a consensus rating of “Buy” and an average price target of $220.38.

Zoetis Profile

Zoetis Inc engages in the discovery, development, manufacture, and commercialization of animal health medicines, vaccines, and diagnostic products and services in the United States and internationally. The company commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep and others; and companion animals comprising dogs, cats, and horses.